Page 118 - Critical Care Notes
P. 118

4223_Tab03_107-130  29/08/14  8:28 AM  Page 112



                        RESP
          ■ Alveolar-arterial (A-a) gradient (PAO 2 / PaO 2 )
            ■ PAO 2 represents the partial pressure of alveolar O 2 (mm Hg).
            ■ PaO 2 represents the partial pressure of arterial O 2 (mm Hg).
            ■ Value is used to calculate the percentage of the estimated shunt.
            ■ Value represents the difference between the alveolar and arterial oxygen
             tension.
            ■ Normal A -a gradient value <15 mm Hg.
            ■ Value is increased in atrial or ventricular septal defects, pulmonary
                                  · ·
             edema, ARDS, pneumothorax, and V/Q mismatch.
          ■ a/A ratio (PaO 2 /PAO 2 ):
            ■ If ratio <0.60, shunt is worsening.
          ■ Estimation of shunt using PaO 2 /FIO 2 (P/F) ratio:
            ■ P/F ratio 500 indicates a 5% shunt.
            ■ P/F ratio 300 indicates a 15% shunt.
            ■ P/F ratio 200 indicates a 20% shunt.
          Management
          ■ Treatment of underlying cause and symptoms
          ■ Continuous positive airway pressure (CPAP), PEEP, or bilevel positive airway
            pressure (BiPAP)
                 Ventilator-Associated Pneumonia (VAP)
          VAP is an airway infection that develops more than 48 hr after the patient is
          intubated. It is associated with increased mortality, prolonged time spent on a
          ventilator, and increased length of ICU/hospital stay.
          Pathophysiology
          VAP is usually caused by gram-negative bacilli or Staphylococcus aureus via
          microaspiration of bacteria that colonize the oropharynx and upper airways or
          bacteria that form a biofilm on or within an endotracheal tube (ETT). The pres-
          ence of an ETT also impairs cough and mucociliary clearance. Suctioning also
          contributes to VAP.
          Clinical Presentation
          VAP manifests with:
          ■ Increased RR, HR, and temperature (>38.3°C or 101°F)
          ■ Increased WBC (>10,000/mm 3 )
          ■ Increased purulent tracheal secretions
          ■ Crackles
          ■ Worsening oxygenation, hypoxemia, PaO 2 /FIO 2 changes
          Diagnostic Tests
          ■ CXR showing new or persistent infiltrates
          ■ Tracheal aspirate and blood cultures
                                112
   113   114   115   116   117   118   119   120   121   122   123